Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Urinary Bladder Neoplasms × Mitomycin × Clear all

Phase

Phase 3 16 Phase 2 10 Phase 1/2 3 Phase NA 1 Phase 4 1 Phase 2/3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1 Recurrence 1 Non-Muscle Invasive Bladder Neoplasms 1 Head and Neck Neoplasms 1 Conjunctival Intraepithelial Neoplasia 1

Interventions

5-aminolevulinic acid hexyl ester 2 remimazolam 1 penpulimab 1 pembrolizumab 1 lornoxicam 1 enfortumab vedotin 1 disitamab vedotin 1 Ultrasonography 1 Tobacco Use Cessation Devices 1 Specimen Handling 1 Psychiatric Rehabilitation 1 Propofol 1 Polymerase Chain Reaction 1 Ofloxacin 1 Neuroleptanalgesia 1 Nephroureterectomy 1 Mitomycin 1 Midazolam 1 Metformin 1 Magnetic Resonance Spectroscopy 1 Injections 1 Hyperthermia, Induced 1 Gene Expression Profiling 1 Fentanyl 1 Early Intervention, Educational 1 Docosahexaenoic Acids 1 Diclofenac 1 Cystoscopy 1 Cystectomy 1 Counseling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03348969 2026-03-03

NICSA

Aarhus University Hospital

Phase 4 Completed

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡